A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia

NCT04254874 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

2019-nCoV

Interventions

DRUG: Abidol hydrochloride
DRUG: Abidol Hydrochloride combined with Interferon atomization

Sponsor

Tongji Hospital